InMed Pharmaceuticals Inc. operates as a pharmaceutical drug development company in the United States. The company researches and develops cannabinoid-based pharmaceuticals products. Its product candidates include INM-901 for Alzheimer's disease, INM-089 for dry age-related macular degeneration, and INM-755, a cannabinol cream. The company was formerly known as Cannabis Technologies Inc. and changed its name to InMed Pharmaceuticals Inc. in October 2014. InMed Pharmaceuticals Inc. was incorporated in 1981 and is based in Vancouver, Canada. Show more
500 West Georgia Street, Vancouver, BC, V6B 0M3, Canada
Market Cap
7.636M
52 Wk Range
$0.57 - $2.50
Previous Close
$1.39
Open
$1.39
Volume
53,681
Day Range
$1.38 - $1.41
Enterprise Value
5.387M
Cash
2.194M
Avg Qtr Burn
-2.965M
Insider Ownership
0.06%
Institutional Own.
52.73%
Qtr Updated
06/30/26
Only showing assets and stage. See catalyst data with a free or premium account. Unlock more data with a free account.
| Drug & Indication | Stage & Event | Catalyst Date |
|---|